Perceptive Advisors’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-229,807
| Closed | -$8.88M | – | 141 |
|
|
2021
Q4 | $8.88M | Sell |
229,807
-163,806
| -42% | -$6.33M | 0.14% | 100 |
|
|
2021
Q3 | $21.3M | Sell |
393,613
-349,086
| -47% | -$18.8M | 0.31% | 67 |
|
|
2021
Q2 | $24.8M | Buy |
+742,699
| New | +$24.8M | 0.32% | 77 |
|
|
2020
Q4 | – | Sell |
-49,751
| Closed | -$738K | – | 144 |
|
|
2020
Q3 | $738K | Buy |
+49,751
| New | +$738K | 0.01% | 116 |
|
|
2017
Q2 | – | Sell |
-465
| Closed | -$25K | – | 136 |
|
|
2017
Q1 | $25K | Buy |
+465
| New | +$25K | ﹤0.01% | 137 |
|
|
2016
Q3 | – | Sell |
-4,742
| Closed | -$312K | – | 193 |
|
|
2016
Q2 | $312K | Buy |
+4,742
| New | +$312K | 0.02% | 129 |
|
|
2015
Q1 | – | Sell |
-6,667
| Closed | -$1.83M | – | 150 |
|
|
2014
Q4 | $1.83M | Buy |
+6,667
| New | +$1.83M | 0.15% | 83 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 105 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 92 |
|